Kazia Therapeutics (KZIA) Interest Coverage Ratio (2009 - 2011)
Kazia Therapeutics (KZIA) reported Interest Coverage Ratio of 52.22 for Q4 2011, down 84.03% on a YoY basis from 327.06 in Q4 2010, and down 84.03% quarter-over-quarter from 327.06 in Q4 2010.
Kazia Therapeutics (KZIA) Interest Coverage Ratio (2009 - 2011) Analysis & Trends
Kazia Therapeutics has reported Interest Coverage Ratio for 3 years, with the latest figure at 52.22 in Q4 2011.
- For the quarter ending Q4 2011, Interest Coverage Ratio fell 84.03% year-over-year to 52.22; the trailing twelve-month figure through Dec 2011 stood at 512.77 (down 53.02% YoY), and the FY2013 full-year result was 12.45, changed N/A from the prior year.
- Interest Coverage Ratio for Q4 2011 stood at 52.22, down from 327.06 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 582.36 in Q4 2009, with the low at 52.22 in Q4 2011.
- Historically, Interest Coverage Ratio has averaged 320.55 across 3 years, with a median of 327.06 in 2010.
- Annual changes were most pronounced in 2010 — Interest Coverage Ratio tumbled 43.84% — and 2011, when it plunged 84.03%.
- Kazia Therapeutics' Interest Coverage Ratio stood at 582.36 in 2009, then plunged by 43.84% to 327.06 in 2010, then sank by 84.03% to 52.22 in 2011.
- The last three Interest Coverage Ratio figures came in at 52.22 (Q4 2011), 327.06 (Q4 2010), and 582.36 (Q4 2009), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Kazia Therapeutics | 1.70 Bn | 1.70 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 52.22 |
| Dec 31, 2010 | 327.06 |
| Dec 31, 2009 | 582.36 |